USANA Health Sciences Inc (USNA)

USANA Health Sciences Inc. is a U.S.-listed common equity on the NYSE under the symbol USNA. The company develops, manufactures, and sells science-based nutritional, personal care, and skincare products across the Asia Pacific, the Americas, and Europe. Its operations are organized into two segments: Direct selling and Hiya Direct-To-Consumer.

USANA’s product lineup includes nutritional optimizers and supplements focused on cardiovascular, skeletal and structural, and digestive health, along with Essentials and CellSentials vitamin and mineral products for children and other age groups. The company also sells meal replacement shakes, snack bars, and related food products aimed at weight management, digestive health, energy, and hydration. Its skincare portfolio includes Celavive, a regimen designed for different skin types and ethnicities. In addition, USANA provides materials and online tools to support associates with product marketing and business development. The company was founded in 1992 and is headquartered in Salt Lake City, Utah.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Next Earnings Date Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
NYSE-USNA
$21.96
55.3% Upside
Bargain
$25
76.8% Upside
Bargain
Fair
0.0%
October 27, 2026
0.5x
0.3x
261.3 M
121.1 M
0.0%
53.7%
5.2
-71.9%
Valuation • Fair Value

USANA Health Sciences Inc (NYSE-USNA) Fair Value by Valuation Model

Review the available estimates for USANA Health Sciences Inc (NYSE-USNA), including Comps Fair Value.

Primary Valuation Read

Fair Value

$21.96

Estimated upside of 55.3% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

Comps Fair Value

$21.96

Comparable-company valuation reference.

Analyst Price Target

$25

Analysts imply upside of 76.8%.

How to read these valuation models

Use the 4 available valuation references for USANA Health Sciences Inc (NYSE-USNA) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for USANA Health Sciences Inc (NYSE-USNA)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

913.4 M

Current operating scale indicator.

Revenue Forecast

909.6 M

Forward revenue estimate.

EBITDA

73.919 M

Current operating profitability reference.

EBITDA Forecast

86.894 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review USANA Health Sciences Inc (NYSE-USNA) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for USANA Health Sciences Inc (NYSE-USNA)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

5

Mid-range quality score.

Altman Z-Score

5.2

Relatively strong balance-sheet zone.

FCF / Net Income

-71.9%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for USANA Health Sciences Inc (NYSE-USNA). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for USANA Health Sciences Inc (NYSE-USNA)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

October 27, 2026

Days to Earnings

39

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for USANA Health Sciences Inc (NYSE-USNA), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for USANA Health Sciences Inc (NYSE-USNA) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for USANA Health Sciences Inc (NYSE-USNA) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for USANA Health Sciences Inc (NYSE-USNA) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for USANA Health Sciences Inc (NYSE-USNA) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for USANA Health Sciences Inc (NYSE-USNA) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ Fast Investor Answers

USANA Health Sciences Inc (NYSE-USNA) Stock FAQ

Data-supported answers about USANA Health Sciences Inc (NYSE-USNA), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$21.96
Estimated upside 55.3%
Valuation Rating
Undervalued
Estimated upside of 55.3%
Analyst Target
$25
Implied upside 76.8%
Financial Health
Fair
Current financial-health read

The current fair value estimate for USANA Health Sciences Inc (NYSE-USNA) is $21.96. This implies an estimated upside of 55.3% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 55.3% versus the current market price.

The available analyst price target for USANA Health Sciences Inc (NYSE-USNA) is $25. The analyst target implies estimated upside of 76.8%.

The current financial health read for USANA Health Sciences Inc (NYSE-USNA) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for USANA Health Sciences Inc (NYSE-USNA) is October 27, 2026.

The latest available data indicates no current dividend yield for USANA Health Sciences Inc (NYSE-USNA).

The current market capitalization listed for USANA Health Sciences Inc is 261.3 M.

The current enterprise value listed for USANA Health Sciences Inc is 121.1 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for USANA Health Sciences Inc is NYSE-USNA, and the stock is listed on NYSE.

USANA Health Sciences Inc (NYSE-USNA) is listed on NYSE.

The current debt-to-total-capital ratio listed for USANA Health Sciences Inc is 0.0%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for USANA Health Sciences Inc is 53.7%. Free float helps investors understand how much of the share base is available for public trading.